RT Journal Article
SR Electronic
T1 Factors impacting prescription practice in primary healthcare setting in India: A case study in Rajasthan
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.17.20133439
DO 10.1101/2020.06.17.20133439
A1 Arup Kumar Das
A1 Shyama Nagarajan
A1 Ruchi Bhargava
A1 Rajesh Ranjan Singh
A1 Ambey Kumar Srivastava
A1 Amitabh Dutta
YR 2020
UL http://medrxiv.org/content/early/2020/06/24/2020.06.17.20133439.abstract
AB Background We present a case of prescription practices in the Indian state of Rajasthan to demonstrate the effect of provider and system level factors, and their interactions on good prescription practices. We have presented two major dimensions of good prescription practice; first, completeness of prescription, a measure of adequacy; and second, appropriateness of prescription, a measure of quality of care (QoC).Method We used mixed method to audit 2801 prescriptions, selected from 24 rural and 7 urban government Primary Health Centres (PHCs) of Rajasthan, India. The findings represent analysis of 97% of the ‘selected prescriptions’ that were considered ‘legible’. The ‘selected prescriptions’ ensure represent variance in patient categories, seasonality and number of OPD foot fall across days in a week. Semi-structured in-depth interviews, followed by Focused Group Discussion (FGD) with providers was undertaken to obtain insights about facilitators and barriers to good prescription practices. We compared descriptive statistics across quintiles on adequacy indicators to understand variations around provider and system level factors; multilevel logistic regression model was used to obtain the adjusted effect. To assess appropriateness of quality of care (QoC), we evaluated 783 prescriptions that had adequate information to compare factors impacting QoC across quintiles. Finally, findings from the FGD was used to substantiate findings from the quantitative analysis.Result We found that prescription practices are outcomes of both provider and system level factors, and their interactions. The documentation of patient complaint, examination findings largely depends on system level factors; 59% and 38%, respectively. The treatment adequacy is largely associated with patient category. Ownership compliance of the doctors, measured in terms of their signature in the prescriptions, emerged as an important factor determining both adequacy and accuracy of prescriptions. We also found that treatment appropriateness, measured in terms of QoC, depends on both provider and system level factors. A conducive environment and trained provider are more likely to provide adequate and appropriate treatment. It is also observed that higher patient load is not a counter-productive to treatment appropriateness. Out of 783 legible prescriptions that were assessed for its appropriateness, only 36% were found inappropriate in terms of their documented justification for the treatment advised.Conclusion There is a need to focus on provider and system level factors to improve prescription practices in primary health care (PHC). We recommend that institutional strengthening at systemic and provider level using innovative ways; such as task shifting to nurses as ‘physician assistants’, and reducing administrative activities of physicians to enhance focus on clinical work can propel better prescription practice.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis was not a clinical trial studyClinical Protocols https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3428-8#CR12 Funding StatementLEHS|WISH and USAIDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IIHMR, Delhi Ethics board approved the studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data and information collected is in excel https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-3428-8#CR12